Get started
Author

Mu-Tzu Chu

Identification of drug-specific public TCR driving severe cutaneous adverse reactions
2019 · Ren-You Pan, Mu-Tzu Chu, et al. · Nature Communications · 124
PDF
Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
2018 · Ren-You Pan, Wen-Hung Chung, et al. · Journal of Immunology Research · 118
PDF
Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions
2015 · Wen-Hung Chung, Ren-You Pan, et al. · Journal of Investigative Dermatology · 116
Rhein, An Anthraquinone Drug, Suppresses the NLRP3 Inflammasome and Macrophage Activation in Urate Crystal-Induced Gouty Inflammation
2019 · Wan-Chun Chang, Mu-Tzu Chu, et al. · The American Journal of Chinese Medicine · 59
Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers
2022 · Shih-Cheng Pao, Mu-Tzu Chu, et al. · Pharmaceutics · 36
PDF
Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators
2023 · Mu-Tzu Chu, Wan-Chun Chang, et al. · Biomedicines · 31
PDF
Granulysin-Based Lymphocyte Activation Test for Evaluating Drug Causality in Antiepileptics-Induced Severe Cutaneous Adverse Reactions
2020 · Mu-Tzu Chu, Chuang-Wei Wang, et al. · Journal of Investigative Dermatology · 27
Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancer
2023 · Shuen-Iu Hung, Mu-Tzu Chu, et al. · Biomedicine & Pharmacotherapy · 11
The risk of anti‐osteoporotic agent‐induced severe cutaneous adverse drug reactions and their association with HLA
2020 · C.‐B. Chen, Y.‐E. Chen, et al. · Journal of the European Academy of Dermatology and Venereology · 11
Works count: 9
Citation count: 533
H-index: 9
I10-index: 9
Year
Topic
Type